Financials

News Ideas Discussions Technicals Forecast Seasonals Options

NRXP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of NRX Pharmaceuticals, Inc.

Total assets of NRXP for Q1 25 is 7.59 M USD, 107.89% more than the previous Q4 24. And total liabilities increased by 21.87% in Q1 25 to 32.75 M USD.

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD